CODI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Compass Diversified Holdings is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock has no strong proprietary buy signal, technical momentum remains weak, analyst coverage is still only Neutral/Market Perform, and recent congressional activity shows net selling rather than buying. Given the uncertainty around financial restatements and divestiture execution, the better call is to avoid buying now and wait for clearer fundamental improvement.
The technical setup is weak. CODI closed at 11.63 after a prior close of 11.42, but the broader trend is still under pressure. MACD histogram is -0.191 and negatively expanding, which signals bearish momentum. RSI_6 at 30.894 is near oversold but not a clear reversal signal. Moving averages are converging, suggesting indecision rather than a confirmed uptrend. Price is hovering around support at 11.369, with resistance at 12.156 and 12.399. The stock trend model also points to softness, with estimates of -3.5% over the next week and -6.01% over the next month.
["Sterno subsidiary sale was described by B. Riley as positive.", "Post-market move was positive at 1.84%, showing some late-session buying interest.", "RSI is near oversold, which can sometimes precede a short-term bounce.", "Open interest is heavily call-skewed, implying some traders are positioning for upside."]
["No news in the recent week, so there is no fresh catalyst driving the stock upward.", "Analysts remain Neutral/Market Perform, with target cuts and uncertainty around divestitures.", "Recent restatement of financials due to accounting unreliability within the Lugano subsidiary is a major overhang.", "Hedge funds are neutral and insiders are neutral, showing no strong confidence signal.", "Congress trading shows 1 sale and 0 purchases in the last 90 days, a bearish signal.", "Proprietary signals show no AI Stock Pick and no SwingMax buy signal.", "Technical momentum is negative and expected near-term price trend is weak."]
No usable latest-quarter financial snapshot was provided because of a data error, so a detailed quarter-over-quarter assessment is not available. Based on the available context, the most important financial issue is the recent restatement of financials tied to the Lugano subsidiary, which implies accounting unreliability and makes the latest quarter harder to trust. The company is also working through divestitures and credit agreement issues, so the operating picture appears more focused on cleanup and restructuring than on clear growth.
Analyst sentiment is cautious. On 2026-04-07, B. Riley raised its price target to $10.50 from $8 but kept a Neutral rating, calling the Sterno sale positive and waiting for more divestitures. On 2026-03-11, Raymond James re-initiated with Market Perform and no target, citing the restatement and saying more work remains to improve credit standing. On 2026-03-03, B. Riley had already cut its target to $8 from $13 while keeping Neutral due to uncertainty around divestitures and 2026 subsidiary performance. Overall, Wall Street’s pros see possible value from asset sales, while the cons focus on uncertainty, accounting issues, and execution risk.
